EZVille, Ltd. Issues a Voluntary Nationwide Recall of Solo Slim®

by Gary Kopycinski on August 9, 2010

Gary Kopycinski Author

More in Recalls:

Conagra Brands, Inc., Recalls Frozen Beef Products Due to Misbranding and Undeclared Allergens August 12, 2022
BrucePac Recalls Ready-to-Eat Chicken Sausage Products Due to Misbranding November 20, 2019
Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA November 14, 2018

Ronkonkoma, NY–(ENEWSPF)–August 9, 2010. EZVille, Ltd. has been informed by the Food and Drug Administration (FDA) that FDA lab analysis of Solo Slim® distributed by the company was found to contain an undeclared drug ingredient. Solo Slim® was found to contain Didesmethyl Sibutramine. Sibutramine is an FDA-approved drug used as an appetite suppressant for weight loss. The FDA has not approved Solo Slim®, therefore the safety and effectiveness of the product is unknown.